Arcutis Biotherapeutics, Inc. (ARQT)

26.65 -0.05 (-0.19%) USD  |  NASDAQ  |  Jan 22, 16:00
26.51 -0.14 (-0.53%) After-Hours: 07:50
More

Arcutis Biotherapeutics CAPEX To Revenue (TTM)

CAPEX To Revenue (TTM) Chart

View CAPEX To Revenue (TTM) for ARQT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View CAPEX To Revenue (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

CAPEX To Revenue (TTM) Range, Past 5 Years

View CAPEX To Revenue (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

CAPEX To Revenue (TTM) Benchmarks

View CAPEX To Revenue (TTM) Benchmarks
Start Trial
CorMedix, Inc. Upgrade
ADMA Biologics, Inc. Upgrade
ANI Pharmaceuticals, Inc. Upgrade
Editas Medicine, Inc. Upgrade
Amicus Therapeutics, Inc. Upgrade